Education
About Us
Working with TipRanks
Follow Us
Sun Pharmaceutical Industries Limited (IN:SUNPHARMA)
:SUNPHARMA
RESEARCH TOOLSreports
SUNPHARMA Analyst Ratings
Moderate Buy
3 Buy
0 Hold
1 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
SUNPHARMA Stock 12 Month Forecast
Average Price Target
₹1,961.25
▲(14.03%Upside)
| Highest Price Target₹2,210 | Average Price Target₹1,961 | Lowest Price Target₹1,500 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Macquarie
₹2,100→₹2,135
Buy
24.13%
Upside
Reiterated
05/20/25
Goldman Sachs
₹1,475→₹1,500
Sell
-12.79%
Downside
Reiterated
04/18/25
HSBC
₹2,280→₹2,000
Buy
16.28%
Upside
Reiterated
03/21/25
J.P. Morgan
₹2,210
Buy
28.49%
Upside
Reiterated
03/11/25
Nomura
₹1,850→₹1,970
Hold
14.53%
Upside
Reiterated
02/04/25
Unknown AnalystICICI Securities
Not Ranked
ICICI Securities
₹2,185
Buy
27.03%
Upside
Reiterated
02/01/25
We maintain with a target price of ₹ 2185 based on 37x FY27E EPS of ₹59.
Bank of America Securities
₹1,955→₹1,940
Hold
12.79%
Upside
Reiterated
01/31/25
Jefferies
₹2,260→₹2,265
Buy
31.69%
Upside
Reiterated
01/31/25
CLSA
₹1,820→₹1,880
Hold
9.30%
Upside
Reiterated
01/23/25
Kotak Mahindra
₹2,045
Buy
18.90%
Upside
Reiterated
12/27/24
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Macquarie
₹2,100→₹2,135
Buy
24.13%
Upside
Reiterated
05/20/25
Goldman Sachs
₹1,475→₹1,500
Sell
-12.79%
Downside
Reiterated
04/18/25
HSBC
₹2,280→₹2,000
Buy
16.28%
Upside
Reiterated
03/21/25
J.P. Morgan
₹2,210
Buy
28.49%
Upside
Reiterated
03/11/25
Nomura
₹1,850→₹1,970
Hold
14.53%
Upside
Reiterated
02/04/25
Unknown AnalystICICI Securities
Not Ranked
ICICI Securities
₹2,185
Buy
27.03%
Upside
Reiterated
02/01/25
We maintain with a target price of ₹ 2185 based on 37x FY27E EPS of ₹59.
Bank of America Securities
₹1,955→₹1,940
Hold
12.79%
Upside
Reiterated
01/31/25
Jefferies
₹2,260→₹2,265
Buy
31.69%
Upside
Reiterated
01/31/25
CLSA
₹1,820→₹1,880
Hold
9.30%
Upside
Reiterated
01/23/25
Kotak Mahindra
₹2,045
Buy
18.90%
Upside
Reiterated
12/27/24
Best Analysts Covering Sun Pharmaceutical Industries Limited
1 Month
xxx
Success Rate
2/3 ratings generated profit
Average Return
-1.90%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 66.67% of your transactions generating a profit, with an average return of -1.90% per trade.
3 Months
xxx
Success Rate
2/3 ratings generated profit
Average Return
+1.83%
reiterated a xxx
rating 16 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +1.83% per trade.
1 Year
Success Rate
2/3 ratings generated profit
Average Return
+1.43%
reiterated a sell rating 2 months ago
Copying Shyam Srinivasan's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +1.43% per trade.
2 Years
xxx
Success Rate
2/3 ratings generated profit
Average Return
+1.43%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 66.67% of your transactions generating a profit, with an average return of +1.43% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
SUNPHARMA Analyst Recommendation Trends
Rating
Jan 25
Feb 25
Mar 25
Apr 25
May 25
Strong Buy
0
0
0
0
0
Buy
5
5
7
4
6
Hold
2
3
3
1
0
Sell
2
2
3
2
2
Strong Sell
0
0
0
0
0
total
9
10
13
7
8
Each month's total comprises the sum of three months' worth of ratings.
SUNPHARMA Financial Forecast
SUNPHARMA Stock Forecast FAQ
What is IN:SUNPHARMA’s average 12-month price target, according to analysts?
Based on analyst ratings, Sun Pharmaceutical Industries Limited’s 12-month average price target is 1,961.25.
What is IN:SUNPHARMA’s upside potential, based on the analysts’ average price target?
Sun Pharmaceutical Industries Limited has 14.03% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Sun Pharmaceutical Industries Limited a Buy, Sell or Hold?
Sun Pharmaceutical Industries Limited has a consensus rating of Moderate Buy, which is based on 3 buy ratings, 0 hold ratings and 1 sell ratings.
What is Sun Pharmaceutical Industries Limited’s share price target?
The average share price target for Sun Pharmaceutical Industries Limited is 1,961.25. This is based on 4 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is ₹2,210.00 ,and the lowest forecast is ₹1,500.00. The average share price target represents 14.03% Increase from the current price of ₹1,720.
The highest analyst share price target is ₹2,210.00 ,and the lowest forecast is ₹1,500.00. The average share price target represents 14.03% Increase from the current price of ₹1,720.
What do analysts say about Sun Pharmaceutical Industries Limited?
Sun Pharmaceutical Industries Limited’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 4 Wall Streets Analysts.
How can I buy shares of Sun Pharmaceutical Industries Limited?
To buy shares of IN:SUNPHARMA, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.